Paul Wood obtained his PhD in Immunology from the JCSMR, Australian National University, in 1982. After a post-doc at Melbourne University, he joined the CSIRO Division of Animal Health as Leader of the TB diagnostic and Vaccine Development program, where he developed the platform TB diagnostic technology now successfully commercialised by CSL and the Australian company, Cellestis. Paul received a number of awards for this research including the CSIRO medal, ASM Diagnostic award and in 2013 The Clunies Ross award. Paul was also the Deputy-Director of the CRC for Vaccine Technology from 1993-2000 and has published over 100 scientific papers.
In 1997, he became Vice President, Global Research and Development in Animal Health at CSL, and in 2004 joined Pfizer AH as Senior Director, A/NZ Biologicals R&D. In 2008, he left Australia to become Executive Director, Global Discovery, Pfizer AH, Kalamazoo , Michigan. In this role he led the Global Discovery team for both pharmaceutical and biological products. Paul returned to Australia in 2012 and established his own consultancy company and accepted an Adjunct Professor position at Monash University. He was also a Director of a start-up AH company Nexvet Biopharma and is one of the Directors of the IMNIS mentoring Initiative. In 2015 he was elected a Fellow (FTSE) of the Australian Academy of Technological Sciences and Engineering. He is on the Board of Women in Science Australia as well as the Chair of AusBiotech’s Ag & Foodtech Committee.
Paul joined GALVmed’s board in September 2016 and is the Chair of the Technical Scientific Advisory Committee.